Embolic Signals Detection Study (Esds) in Candidates for Surgical Carotid Revascularisation
1 other identifier
observational
120
1 country
1
Brief Summary
About 20% of strokes are caused by emboli deriving from a carotid plaque. In symptomatic patients with carotid stenosis grater than 70% the Carotid Endarterectomy (CEA) reduces stroke risk by about 75% and is generally accepted as being cost effective. However also in these cases there is a part of the population that, according to the morphological plaque characteristics, could better benefit from a conservative medical treatment. Improving the Best Medical Treatment, the situation seems to be even less clear in asymptomatic patients, where probably it would need to treat at least 32 patients in order to prevent one single ictus. Different parameters have been considered in order to determine, among the asymptomatic patients the ones that more than others could benefit from a surgical revascularisation instead of a medical treatment. Between these parameters, the quality of the plaque (vulnerability) and the micro-embolic signals (MES) detection with the Transcranial Doppler (TCD) Holter seems to be the most relevant. Another interesting aspect is trying to establish whether plaques can determine a different embolic risk in relation to the different histological findings. Therefore, it seems interesting and reasonable trying to establish a correlation between these two parameters in asymptomatic patients as in the symptomatic ones in order to make more and more appropriate a surgical plaque removal according to the specific risk of each patient in a set of tailored surgery. It consists in a descriptive observational study, since it intends to describe the embolic signals detection (MES) counted in automatic way with the TCD Holter, in patients affected by carotid stenosis, before and after the surgical operation. In particular it consists in a monocentric, longitudinal, prospective cohort study since it intends to analyse a group of patients (already candidates to CEA) that experiences a specific event (MES) before and after the surgical plaque removal, in a precise span of time. Since the treatment, removing the plaque, should remove the embolic focus too, a significant reduction of microembolic signals in post-operative time is expected. This reduction has been esteemed around about the 70% among candidates to CEA. Patients taken on responsibility of the equipe will undergo an ultrasonographic investigation for the carotid stenosis, histological characterization of the plaque based on the Gray-Weale classification and TCD-Holter for MES.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 27, 2018
CompletedFirst Submitted
Initial submission to the registry
June 25, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Posted
Study publicly available on registry
November 26, 2021
CompletedNovember 26, 2021
November 1, 2021
3 years
June 25, 2021
November 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
MES COUNT
number of MES
before surgery
MES COUNT
number of MES
24 hours after surgery
MES COUNT
number of MES
after 30 days from the surgery
Secondary Outcomes (1)
RISK RATE
through study completion, an average of 60 days
Eligibility Criteria
We selected patients already got in touch with the hospital, already put in list for a carotid surgical revascularization.
You may qualify if:
- Informed consent signed
- Age\>18y.o.
- Carotid stenosis \>70% and/or vulnerable plaque
You may not qualify if:
- Inability to give the informed consent
- Age\<18y.o.
- Carotid stenosis \< 70 %
- Patients already treated with CEA in the same seat
- Impossibility to find the insonation window
- Patients not in best medical treatment therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OCB Baggiovara, AOU Modena
Modena, 41126, Italy
Related Publications (1)
Pizzarelli G, Gennai S, Leone N, Covic T, Moratto R, Silingardi R. Transcranial Doppler detects micro emboli in patients with asymptomatic carotid stenoses undergoing endarterectomy. J Vasc Surg. 2023 Mar;77(3):811-817.e2. doi: 10.1016/j.jvs.2022.10.003. Epub 2022 Oct 13.
PMID: 36243263DERIVED
Biospecimen
carotid plaque
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roberto Moratto, Dr
AOU Modena e Reggio Emilia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Ginevra Pizzarelli, Medico in Formazione Specialistica
Study Record Dates
First Submitted
June 25, 2021
First Posted
November 26, 2021
Study Start
June 27, 2018
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
November 26, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share